113 related articles for article (PubMed ID: 2746510)
1. Selective 5-hydroxytryptamine2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-second schedule.
Marek GJ; Li AA; Seiden LS
J Pharmacol Exp Ther; 1989 Jul; 250(1):52-9. PubMed ID: 2746510
[TBL] [Abstract][Full Text] [Related]
2. Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule.
Marek GJ; Seiden LS
J Pharmacol Exp Ther; 1988 Feb; 244(2):650-8. PubMed ID: 2894458
[TBL] [Abstract][Full Text] [Related]
3. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior.
Marek GJ; Li AA; Seiden LS
J Pharmacol Exp Ther; 1989 Jul; 250(1):60-71. PubMed ID: 2746511
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule.
O'Donnell JM; Marek GJ; Seiden LS
Neurosci Biobehav Rev; 2005; 29(4-5):785-98. PubMed ID: 15893376
[TBL] [Abstract][Full Text] [Related]
5. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
Lucki I; Nobler MS; Frazer A
J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
[TBL] [Abstract][Full Text] [Related]
6. Differential-reinforcement-of-low-rate 72-second schedule: selective effects of antidepressant drugs.
O'Donnell JM; Seiden LS
J Pharmacol Exp Ther; 1983 Jan; 224(1):80-8. PubMed ID: 6848751
[TBL] [Abstract][Full Text] [Related]
7. Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement.
Fletcher PJ; Korth KM; Robinson SR; Baker GB
Psychopharmacology (Berl); 2002 Jul; 162(3):282-91. PubMed ID: 12122486
[TBL] [Abstract][Full Text] [Related]
8. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
9. Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.
Cohen ML; Colbert WE
J Pharmacol Exp Ther; 1986 Jun; 237(3):713-8. PubMed ID: 3712277
[TBL] [Abstract][Full Text] [Related]
10. Effects of serotonin receptor antagonists on punished responding maintained by stimulus-shock termination or food presentation in squirrel monkeys.
Brady LS; Barrett JE
J Pharmacol Exp Ther; 1985 Jul; 234(1):106-12. PubMed ID: 4009495
[TBL] [Abstract][Full Text] [Related]
11. Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats.
Bagdy G; Szemeredi K; Kanyicska B; Murphy DL
J Pharmacol Exp Ther; 1989 Jul; 250(1):72-8. PubMed ID: 2746512
[TBL] [Abstract][Full Text] [Related]
12. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
Cohen ML; Fuller RW; Kurz KD; Parli CJ; Mason NR; Meyers DB; Smallwood JK; Toomey RE
J Pharmacol Exp Ther; 1988 Jan; 244(1):106-12. PubMed ID: 3335993
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of isoproterenol administered into the hippocampus, frontal cortex, or amygdala on behavior of rats maintained by differential reinforcement of low response rate.
Zhang HT; Frith SA; Wilkins J; O'Donnell JM
Psychopharmacology (Berl); 2001 Dec; 159(1):89-97. PubMed ID: 11797075
[TBL] [Abstract][Full Text] [Related]
14. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
15. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
Cushing DJ; Cohen ML
J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
[TBL] [Abstract][Full Text] [Related]
16. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
[TBL] [Abstract][Full Text] [Related]
17. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
Germonpré PR; Joos GF; Pauwels RA
Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
[TBL] [Abstract][Full Text] [Related]
18. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effects of 5-hydroxytryptamine1A receptor agonists on operant responding under a response duration differentiation schedule.
Kinney GG; Griffith JC; Hudzik TJ
Behav Pharmacol; 1998 Jul; 9(4):309-18. PubMed ID: 10065919
[TBL] [Abstract][Full Text] [Related]
20. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
